TTM Technologies CapEx increased by 54.0% to $106.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 68.7%, from $63.32M to $106.85M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 37.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.84M | $17.45M | $19.87M | $23.45M | $26.48M | $26.32M | $26.64M | $31.00M | $49.47M | $33.70M | $46.08M | $49.34M | $39.47M | $40.90M | $56.03M | $63.32M | $60.41M | $99.45M | $69.39M | $106.85M |
| QoQ Change | — | -23.6% | +13.8% | +18.0% | +13.0% | -0.6% | +1.2% | +16.4% | +59.6% | -31.9% | +36.7% | +7.1% | -20.0% | +3.6% | +37.0% | +13.0% | -4.6% | +64.6% | -30.2% | +54.0% |
| YoY Change | — | — | — | — | +16.0% | +50.8% | +34.1% | +32.2% | +86.8% | +28.0% | +73.0% | +59.2% | -20.2% | +21.4% | +21.6% | +28.3% | +53.1% | +143.2% | +23.8% | +68.7% |